Product news (18 September 2010)
The list of changes to summaries of product characteristics is not exhaustive. SPCs for a number of medicines licensed in the UK are available online
Azactam (aztreonam) injection 1g and 2g is available again from Bristol-Myers Squibb. However, full customer supply is still not guaranteed says BMS.
Hospitals are asked to prioritise the ordering of Azactam for patients who are in the greatest need, and continue to consider using alternative treatment options where available.
BMS is unable to guarantee that an out of stock situation will not happen again.
Further information on 01244 586250.
Medical information on 0800 731 1736.
Gopten (trandolapril) hard capsules 2mg are now available from Abbott.
Further information on 01628 773355.
Heparin calcium solution for injection or concentrate for solution for infusion 25,000 IU/ml is available again from Wockhardt.
Baxan (cefadroxil) suspension 125mg/5ml has been discontinued by Bristol-Myers Squibb.
The 500mg capsules and 250mg/5ml and 500mg/5ml suspensions will be discontinued on 1 December 2010 or when stocks are exhausted.
Orthoclone OKT3 (muromonab-CD3) solution for injection 1mg/ml has been discontinued by Janssen-Cilag.
The withdrawal is worldwide and will also affect named patient suppliers that have been available in the UK and Ireland.
Further information on 01494 567444.
Sanofi-aventis is to restructure its insulin product range to limit it to two injection devices.
The company’s range of insulins is to be made available in the ClikSTAR (reuseable pen) device, with Lantus, Apidra and Insuman Comb 25 being additionally made available in the SoloStar (pre-filled pen) device.
The older pen devices will be discontinued from 31 December 2011.
Patients with queries can call 0845 606 6887.
Citation: The Pharmaceutical Journal URI: 11025072
Recommended from Pharmaceutical Press